Callos Andrew sold CYTK

July 30, 2026 · Form 4 insider transaction

Callos Andrew sold 14,000 shares of Cytokinetics, Incorporated at $79.88 per share, a transaction worth $1.12M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.